Refresh

Solvay Pharma India Ltd.[Amalgamated] - Research Center

532447 DUPHARPH Group (N.A.) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Dec ' 10 Dec ' 09 Dec ' 08 Dec ' 07 Dec ' 06
Income

Operating income

294.28 242.18 201.64 167.77 144.09
Expenses

Material consumed

118.60 106.85 86.28 70.26 63.51

Manufacturing expenses

4.16 3.72 3.05 2.54 2.30

Personnel expenses

33.74 26.48 21.38 18.82 17.31

Selling expenses

32.59 18.80 13.44 11.76 11.65

Adminstrative expenses

31.22 25.64 29.58 19.92 18.06

Expenses capitalised

- - - - -

Cost of sales

220.32 181.48 153.73 123.30 112.83

Operating profit

73.97 60.69 47.91 44.47 31.27

Other recurring income

4.98 3.06 3.71 3.21 3.22

Adjusted PBDIT

78.95 63.75 51.62 47.68 34.49

Financial expenses

0.49 0.49 0.48 0.31 0.23

Depreciation

3.20 4.57 1.33 4.97 4.59

Other write offs

- - - - -

Adjusted PBT

75.26 58.69 49.81 42.40 29.67

Tax charges

24.99 20.63 17.41 14.78 10.79

Adjusted PAT

50.27 38.06 32.41 27.62 18.87

Non recurring items

0.58 0.72 0.40 0.50 -0.14

Other non cash adjustments

- 1.25 - -0.12 -

Reported net profit

50.85 40.03 32.80 28.00 18.73

Earnigs before appropriation

153.02 125.37 98.96 92.42 72.03

Equity dividend

12.88 16.41 8.84 20.20 4.04

Preference dividend

- - - - -

Dividend tax

2.14 2.79 1.50 3.06 0.57

Retained earnings

138.00 106.17 88.63 69.16 67.43
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com